Radiation Oncology
Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.
Recent Discussions
How would you manage a metastatic lesion abutting the optic structures (globe, optic nerve, etc)?
Generally, if I'm treating a metastatic lesion abutting an OAR - in this case, it's an optic nerve - I try to keep my Dmax to the optic nerve/chiasm to 8 Gy (allow up to 10 Gy if needed). If I can't achieve those constraints, I would favor fractionated radiosurgery. There are some papers looking at ...
In the setting of single or multi-fraction cranial radiosurgery, do you have different constraints for the dose to the optic tract just posterior to the chiasm, compared to the constraints for the chiasm?
I treat the post-chiasmatic tract the same as the pre-chiasmatic nerve segments in a single x-shaped structure. As for the optic striations, as they blend into the brain, they get treated the same as the rest of the brain.
Would you treat T1a glottic cancer with single vocal cord irradiation using IGRT?
Treating glottis larynx ca with IMRT/VMAT sparing the carotid artery has been reported by several institutions and is straightforward (for example, here). The benefits are supposed to be reduced cerebrovascular events, however, the utility of this approach is unknown, taking into account the relativ...
What is your approach to locally advanced pancreatic cancer that has not progressed after neoadjuvant chemotherapy +/- chemoradiation but remains unresectable?
NRG GI011 was recently activated across the NCTN and will test ablative radiotherapy in this setting. This is a pragmatic and potentially practice-changing trial. Consider activating it at your center. Here is a nice summary from the PI @Dr. First Lasthttps://www.youtube.com/watch?v=MNsS7pHqZIk.
In what circumstances would you recommend adjuvant radiation for a keratocanthoma with SCC after resection?
KA by itself (in the absence of SCC) is at the interface of benign and malignant. In a pure KA, if margins are negative, no further RT is needed. If there is SCC mixed, as can happen even with BCCs, the adjuvant RT indication rules pertaining to SCC prevail.
For those treating osteoarthritis with LDRT, is there any concern of adverse effects or decreased efficacy in patients with osteoporosis?
I’m not aware of any data specifically looking at the efficacy of LDRT for OA in patients with osteoporosis. The anti-inflammatory mechanism of LDRT should not be altered by the bone thickness/quality, but repetitive “injury” contributing to OA may be different if the cause is related to bone qualit...
What evidence supports the use of high tangents for pN1mic breast cancer?
This is a great question. To add to the excellent answers from @Dr. First Last and @Dr. First Last, here are some of my thoughts on this topic:At the time of MA.20, the size of nodal metastasis was not routinely measured so it is unclear what percent of patients in MA.20, if any, had micrometastases...
Do you prescribe silvadene cream for patients with a sulfa allergy?
No. I will consider hydrogel wound dressings in those situations
What is your preferred method for adding bolus, at CT sim or virtual bolus?
Absolutely, should always apply at sim. Gives you an opportunity to work out the appropriate positioning of the patient to optimize bolus conformality and to select the appropriate bolus type (frequently Superflab but often you don’t know until you get the patient on the sim table whether custom mol...
Is ultrahypofractionation appropriate for a B51 candidate receiving breast-only radiation?
"I believe in the data of biologic equivalence, and I just treated patient X with ultrahypofractionation (UHFRT)...but I can't treat patient Y (who looks extremely similar to patient X, with a few idiosyncrasies) with UHFRT...because '"reasons"' ...*scratches chin* Hard as it may be to believe, ther...